Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/29729
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWitard, Oliveren_UK
dc.date.accessioned2019-06-26T00:03:12Z-
dc.date.available2019-06-26T00:03:12Z-
dc.date.issued2015-05-01en_UK
dc.identifier.urihttp://hdl.handle.net/1893/29729-
dc.description.abstractFirst paragraph: Protein-based fitness products are now big business. Once aimed largely at athletes and hardcore gym-goers seeking to “bulk up”, protein shakes, powders and bars are now being consumed by “ordinary” people seeking to lose weight or tone their bodies. UK sales increased from £73m in 2007 to £170m in 2012 and are expected to reach £358m by 2017.en_UK
dc.language.isoenen_UK
dc.publisherThe Conversation Trusten_UK
dc.relationWitard O (2015) Beach body' row misses the key points about protein and weight loss. The Conversation. 01.05.2015.en_UK
dc.rightsThe Conversation uses a Creative Commons Attribution NoDerivatives licence. You can republish their articles for free, online or in print. Licence information is available at: http://creativecommons.org/licenses/by-nd/4.0/en_UK
dc.rights.urihttp://creativecommons.org/licenses/by-nd/4.0/en_UK
dc.subjectDieten_UK
dc.subjectExerciseen_UK
dc.subjectWeight lossen_UK
dc.subjectDietary supplementsen_UK
dc.subjectThe science behind weight lossen_UK
dc.subjectFitnessen_UK
dc.subjectProteinen_UK
dc.subjectMusclesen_UK
dc.subjectDietingen_UK
dc.subjectwhey proteinen_UK
dc.subjectLosing weighten_UK
dc.titleBeach body' row misses the key points about protein and weight lossen_UK
dc.typeNewspaper/Magazine Articleen_UK
dc.citation.publicationstatusPublisheden_UK
dc.type.statusVoR - Version of Recorden_UK
dc.contributor.funderLucozade Ribena Suntory Ltden_UK
dc.contributor.funderGlaxoSmithKlineen_UK
dc.citation.date01/05/2015en_UK
dc.publisher.addressLondonen_UK
dc.description.noteshttps://theconversation.com/beach-body-row-misses-the-key-points-about-protein-and-weight-loss-40997en_UK
dc.contributor.affiliationSporten_UK
dc.identifier.wtid1385027en_UK
dc.contributor.orcid0000-0002-5875-8397en_UK
dcterms.dateAccepted2015-05-01en_UK
dc.date.filedepositdate2019-06-04en_UK
rioxxterms.apcnot chargeden_UK
rioxxterms.typeOtheren_UK
rioxxterms.versionVoRen_UK
local.rioxx.authorWitard, Oliver|0000-0002-5875-8397en_UK
local.rioxx.projectProject ID unknown|GlaxoSmithKline|http://dx.doi.org/10.13039/100004330en_UK
local.rioxx.projectProject ID unknown|Lucozade Ribena Suntory Ltd|en_UK
local.rioxx.freetoreaddate2019-06-04en_UK
local.rioxx.licencehttp://creativecommons.org/licenses/by-nd/4.0/|2019-06-04|en_UK
local.rioxx.filenameWitard-Conversation-2015.pdfen_UK
local.rioxx.filecount1en_UK
Appears in Collections:Faculty of Health Sciences and Sport Newspaper/Magazine Articles

Files in This Item:
File Description SizeFormat 
Witard-Conversation-2015.pdfFulltext - Published Version1.22 MBAdobe PDFView/Open


This item is protected by original copyright



A file in this item is licensed under a Creative Commons License Creative Commons

Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.